Skip to content
2000
Volume 15, Issue 3
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

Background

Polycystic ovarian syndrome (PCOS) is a prevalent endocrine and metabolic condition seen in premenopausal women. A number of pharmacological agents like metformin, oral contraceptives, and anti-androgen agents have been used to treat PCOS and its associated implications, but it has been associated with numerous negative effects like fatal and nonfatal lactic acidosis, weight gain, cardiovascular, and hepatic toxicity.

Methodology

This study considered the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guideline where a vast number of article sources from different scientific databases like Google Scholar (https://scholar.google.com/), PubMed (https://pubmed.ncbi.nlm.nih.gov/), and Web of Science (https://mjl.clarivate.com/search-results) were screened out.

Results

From a total of 154 studies, 24 studies were screened out following the inclusion and exclusion criteria, which reported 24 different plants that were used against PCOS preclinically. Details of various plants used, including their respective families, plant parts utilized, extraction methods employed, formulations developed, animal models of polycystic ovary syndrome (PCOS) utilized, and the geographical locations within India where the research has been conducted are all documented.

Conclusion

This systematic review is the first in India to report the pre-clinical studies of medicinal plants against PCOS, and it provides a thorough summary of the application of medicinal plants for the management of PCOS. Nonetheless, molecular level investigations on the plants utilized, their bioactive phytoconstituent responsible for the anti-PCOS activity, the probable mechanism of action and the pathway through which they conserve their effect, the effective dose, and the potential adverse effects are the need of time.

Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155303329240509115336
2024-05-16
2025-09-07
Loading full text...

Full text loading...

References

  1. GuY. ZhouG. ZhouF. WuQ. MaC. ZhangY. DingJ. HuaK. Life modifications and PCOS: Old story but new tales.Front. Endocrinol.20221380889810.3389/fendo.2022.808898 35498415
    [Google Scholar]
  2. PatelS. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.J. Steroid Biochem. Mol. Biol.2018182273610.1016/j.jsbmb.2018.04.008 29678491
    [Google Scholar]
  3. Escobar-MorrealeH.F. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment.Nat. Rev. Endocrinol.201814527028410.1038/nrendo.2018.24 29569621
    [Google Scholar]
  4. GoodarziM.O. DumesicD.A. ChazenbalkG. AzzizR. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis.Nat. Rev. Endocrinol.20117421923110.1038/nrendo.2010.217 21263450
    [Google Scholar]
  5. BoomsmaC.M. EijkemansM.J.C. HughesE.G. VisserG.H.A. FauserB.C.J.M. MacklonN.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.Hum. Reprod. Update200612667368310.1093/humupd/dml036 16891296
    [Google Scholar]
  6. ÖzdemirS. ÖzdemirM. GörkemliH. KiyiciA. BodurS. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.Acta Obstet. Gynecol. Scand.201089219920410.3109/00016340903353284 19900078
    [Google Scholar]
  7. NormanR.J. DewaillyD. LegroR.S. HickeyT.E. Polycystic ovary syndrome.Lancet2007370958868569710.1016/S0140‑6736(07)61345‑2 17720020
    [Google Scholar]
  8. CunhaA. PóvoaA.M. Infertility management in women with polycystic ovary syndrome: A review.Porto Biomed. J.202161e11610.1097/j.pbj.0000000000000116 33532657
    [Google Scholar]
  9. ChaudhuriA. Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies.Obes. Med.20233910048010.1016/j.obmed.2023.100480
    [Google Scholar]
  10. JabeenA. YaminiV. Rahman AmberinaA. Dinesh EshwarM. VadakedathS. BegumG.S. KandiV. Polycystic ovarian syndrome: Prevalence, predisposing factors, and awareness among adolescent and young girls of south india.Cureus2022148e2794310.7759/cureus.27943 36120281
    [Google Scholar]
  11. NidhiR. PadmalathaV. NagarathnaR. AmritanshuR. Prevalence of polycystic ovarian syndrome in Indian adolescents.J. Pediatr. Adolesc. Gynecol.201124422322710.1016/j.jpag.2011.03.002 21600812
    [Google Scholar]
  12. Behboudi-GandevaniS. Ramezani TehraniF. Rostami DovomM. FarahmandM. Bahri KhomamiM. NoroozzadehM. KabirA. AziziF. Insulin resistance in obesity and polycystic ovary syndrome: Systematic review and meta-analysis of observational studies.Gynecol. Endocrinol.201632534335310.3109/09513590.2015.1117069 27052492
    [Google Scholar]
  13. EhrmannD.A. BarnesR.B. RosenfieldR.L. CavaghanM.K. ImperialJ. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care199922114114610.2337/diacare.22.1.141 10333916
    [Google Scholar]
  14. MoranL. TeedeH. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Hum. Reprod. Update200915447748810.1093/humupd/dmp008 19279045
    [Google Scholar]
  15. MurriM. Luque-RamírezM. InsenserM. Ojeda-OjedaM. Escobar-MorrealeH.F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis.Hum. Reprod. Update201319326828810.1093/humupd/dms059 23303572
    [Google Scholar]
  16. BarryJ.A. KuczmierczykA.R. HardimanP.J. Anxiety and depression in polycystic ovary syndrome: A systematic review and meta-analysis.Hum. Reprod.20112692442245110.1093/humrep/der197 21725075
    [Google Scholar]
  17. StangM. WysowskiD.K. Butler-JonesD. Incidence of lactic acidosis in metformin users.Diabetes Care199922692592710.2337/diacare.22.6.925 10372243
    [Google Scholar]
  18. LopezL.M. EdelmanA. Chen-MokM. TrussellJ. HelmerhorstF.M. Progestin-only contraceptives: Effects on weight.Cochrane Database Syst. Rev.2011CD0088154CD00881510.1002/14651858.CD008815.pub2 21491411
    [Google Scholar]
  19. KemmerenJ.M. AlgraA. GrobbeeD.E. Third generation oral contraceptives and risk of venous thrombosis: Meta-analysis.BMJ2001323730513113410.1136/bmj.323.7305.131 11463678
    [Google Scholar]
  20. BarbhuiyaP.A. LaskarA.M. MazumdarH. DuttaP.P. PathakM.P. DeyB.K. SenS. Ethnomedicinal practices and traditional medicinal plants of barak valley, Assam: A systematic review.J. Pharmacopuncture202225314918510.3831/KPI.2022.25.3.149 36186100
    [Google Scholar]
  21. NasimN. SandeepI.S. MohantyS. Plant-derived natural products for drug discovery: Current approaches and prospects.Nucleus202265339941110.1007/s13237‑022‑00405‑3 36276225
    [Google Scholar]
  22. ErfeJ.M. ChoeJ.K. Introduction: The global health movement.Yale J. Biol. Med.2014873227229 25330545
    [Google Scholar]
  23. TsobouR. MapongmetsemP.M. Van DammeP. Medicinal plants used for treating reproductive health care problems in cameroon, central africa1.Econ. Bot.201670214515910.1007/s12231‑016‑9344‑0 27429475
    [Google Scholar]
  24. ChakrabortyP. Herbal genomics as tools for dissecting new metabolic pathways of unexplored medicinal plants and drug discovery.Biochim. Open2018691610.1016/j.biopen.2017.12.003 29892557
    [Google Scholar]
  25. PanmeiR. GajurelP.R. SinghB. Ethnobotany of medicinal plants used by the Zeliangrong ethnic group of Manipur, northeast India.J. Ethnopharmacol.201923516418210.1016/j.jep.2019.02.009 30738117
    [Google Scholar]
  26. PokaleS.B. JadhavG. Piper longum (Linn.) restores ovarian function in Letrozole induced PCOS in Rats: Comparison with Metformin and Clomiphene citrate.Res J Pharm Technol2021145190519610.52711/10.52711/0974‑360X.2021.00903
    [Google Scholar]
  27. NampoothiriL.P. DesaiB.N. MaharjanR.H. Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.Pharmacognosy Res.20124210911510.4103/0974‑8490.94736 22518083
    [Google Scholar]
  28. JitendraP.A. PravinT.A. Prospective use of Tephrosia Purpurea in remedial treatment of PCOS: Study in wistar rat.Int. Res. J. Biol. Sci.2012116
    [Google Scholar]
  29. KakadiaN. PatelP. DeshpandeS. ShahG. Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome.J. Tradit. Complement. Med.20199433634510.1016/j.jtcme.2018.03.001 31453130
    [Google Scholar]
  30. PachiappanS. RamalingamK. BalasubramanianA. Evaluation of Gymnema sylvestre R. Br. against letrozole induced polycystic ovarian syndrome in rats.Res J Pharm Technol20231638539010.52711/0974‑360X.2023.00066
    [Google Scholar]
  31. SaiyedA. JahanN. MakbulS.A.A. AnsariM. BanoH. HabibS.H. Effect of combination of Withania somnifera Dunal and Tribulus terrestris Linn on letrozole induced polycystic ovarian syndrome in rats.Integr. Med. Res.20165429330010.1016/j.imr.2016.10.002 28462131
    [Google Scholar]
  32. RaniR. ChitmeH.R. KukretiN. PantP. Abdel-WahabB.A. KhateebM.M. HabeebM.S. BakirM.B. Regulation of insulin resistance, lipid profile and glucose metabolism associated with polycystic ovary syndrome by tinospora cordifolia.Nutrients20231510223810.3390/nu15102238 37242122
    [Google Scholar]
  33. HugarA.L. KanjikarA.P. LondonkarR.L. A novel potential reproductive effects of pterocarpus marsupium methanolic extract on testosterone propionate induced polycystic ovary syndrome in female albino rats.Endocr. Metab. Immune Disord. Drug Targets201717431732310.2174/1871530317666170912153934 28901866
    [Google Scholar]
  34. SoumyaV. MuzibY.I. VenkateshP. HariprasathK. GC-MS analysis of Cocus nucifera flower extract and its effects on heterogeneous symptoms of polycystic ovarian disease in female Wistar rats.Chin. J. Nat. Med.201412967768410.1016/S1875‑5364(14)60103‑5 25263979
    [Google Scholar]
  35. de VriesR.B.M. HooijmansC.R. LangendamM.W. van LuijkJ. LeenaarsM. Ritskes-HoitingaM. WeverK.E. A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies.Evid. Based Preclin. Med.2015211910.1002/ebm2.7
    [Google Scholar]
  36. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ202137271n7110.1136/bmj.n71 33782057
    [Google Scholar]
  37. NampoothiriL. MaharjanR. NagarP.S. Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model.J. Ayurveda Integr. Med.20101427327910.4103/0975‑9476.74090 21731374
    [Google Scholar]
  38. RadhaM. PadmanabhiN. LaxmipriyaN. Evaluation of Aloe barbadensis mill. Gel on letrozole induced polycystic ovarian syndrome (PCOS) rat model- A dose dependent study.Int. J. Pharm. Sci. Res.2014552935300
    [Google Scholar]
  39. GhaganeS. ToragallM. AkbarA.A. HiremathM. Effect of Aloe vera (Barbadensis Mill) on letrozole induced polycystic ovarian syndrome in swiss albino mice.J. Hum. Reprod. Sci.202215212613210.4103/jhrs.jhrs_22_22 35928465
    [Google Scholar]
  40. ThakorA.P. PatelA.J. Normalizing of estrous cycle in polycystic ovary syndrome (PCOS) induced rats with Tephrosia purpurea (Linn.).Pers. J. Appl. Nat. Sci.20146119720110.31018/jans.v6i1.400
    [Google Scholar]
  41. MurugesanB.M. MuralidharanP. HariR. Effect of ethanolic seed extract of Caesalpinia bonducella on hormones in mifepristone induced PCOS rats.J. Appl. Pharm. Sci.2020102727610.7324/JAPS.2020.102012
    [Google Scholar]
  42. SunandSK YellowM Betel leaf extract amends dehydroepiandrosterone induced pcos related hormonal abnormality and histopathological alterations in rat model.PJ2019111442114810.5530/pj.2019.11.223
    [Google Scholar]
  43. BhuvaneshwariS. PoornimaR. AveralH.I. Effect of Pergularia daemia in polycystic ovary syndrome induced rat ovaries and thyroid gland.Int. J. Recent Sci. Res.2015623902394
    [Google Scholar]
  44. PatelS. PatelS.V. MaruH. ChavdaV.K. ShahJ.N. Ethanolic extract of Azadirachta indica ameliorates ovarian defects through phosphoinositide-3 kinase inhibition in a rat model of polycystic ovary syndrome.Asian Pac. J. Reprod.20211012110.4103/2305‑0500.306434
    [Google Scholar]
  45. KausarF. RatherM.A. BashirS.M. AlsaffarR.M. NabiS. AliS.I. GoswamiP. AhmadA. RashidS. WaliA.F. Ameliorative effects of Cuscuta reflexa and Peucedanum grande on letrozole induced polycystic ovary syndrome in Wistar rats.Redox Rep.20212619410410.1080/13510002.2021.1927396 34018905
    [Google Scholar]
  46. SreesailaN.P. Effect of ethanolic extracts of Amorphophallus paeoniifolius and Gymnema sylvestre on female wistar rats with estradiol induced polycystic ovarian syndrome.World J. Pharm. Res.2018710531060
    [Google Scholar]
  47. PriyaK.H. MuralidharanP. Protective effect of Coscinium fenestratum bark extract on letrozole induced polycystic ovary syndrome (pcos) in sprague dawley rats.J. Pharm. Res. Int.20233516111710.9734/jpri/2023/v35i167381
    [Google Scholar]
  48. BishtA. GururaniR. JainS. ShuklaR. DwivediJ. SharmaS. Cedrus deodara (Roxb. ex D.Don) G.Don bark fraction ameliorates metabolic, endocrine and ovarian dynamics in rats experiencing polycystic ovarian syndrome.J. Ethnopharmacol.202330611620610.1016/j.jep.2023.116206 36690306
    [Google Scholar]
  49. SoumyaV. MuzibY.I. VenkateshP. A novel method of extraction of bamboo seed oil (Bambusa bambos Druce) and its promising effect on metabolic symptoms of experimentally induced polycystic ovarian disease.Indian J. Pharmacol.201648216216710.4103/0253‑7613.178833 27127318
    [Google Scholar]
  50. RamachandranS. NikithaJ. GopiC. AmalaM. DhanarajuM.D. Effect of Prunus dulcis and Salvia hispenica in the management of polycystic ovary syndrome in Wistar rats.J. Taibah Univ. Med. Sci.202015212212810.1016/j.jtumed.2020.02.002 32368208
    [Google Scholar]
  51. JangamA. KotipalliR.S.S. PatnaikS.S. KasireddyB. GajaS.K. SreedharB. JeraldM.K. AddlagattaA. MuralidharanK. Gymnema sylvestre extract improves PCOS by altering the YAP1 protein in the mouse ovary via mitochondrial changes.Phytomedicine Plus20244110051510.1016/j.phyplu.2023.100515
    [Google Scholar]
  52. PandeyM.M. RastogiS. RawatA.K.S. Indian traditional ayurvedic system of medicine and nutritional supplementation.Evid. Based Complement. Alternat. Med.2013201311210.1155/2013/376327 23864888
    [Google Scholar]
  53. AdhikariP.P. PaulS.B. History of Indian traditional medicine: A medical inheritance.Asian J. Pharm. Clin. Res.201811142110.22159/ajpcr.2018.v11i1.21893
    [Google Scholar]
  54. ShiY. ZhangC. LiX. Traditional medicine in India.J. Tradit. Chin. Med. Sci.20218S51S5510.1016/j.jtcms.2020.06.007
    [Google Scholar]
  55. SenS. ChakrabortyR. Toward the integration and advancement of herbal medicine: A focus on traditional Indian medicine.Botanics20155333410.2147/BTAT.S66308
    [Google Scholar]
  56. HossainM.A. SharfarazA. HasanM.I. SomadderP.D. HaqueM.A. SarkerM.R. AlamM.M. Wasaf HasanA.M. SohelM. RahmanM.H. Molecular docking and pharmacology study to explore bio-active compounds and underlying mechanisms of Caesalpinia bonducella on polycystic ovarian syndrome.Informatics in Medicine Unlocked20223310107310.1016/j.imu.2022.101073
    [Google Scholar]
/content/journals/npj/10.2174/0122103155303329240509115336
Loading
/content/journals/npj/10.2174/0122103155303329240509115336
Loading

Data & Media loading...

Supplements

PRISMA checklist is available on the publisher's website along with the published article.


  • Article Type:
    Review Article
Keyword(s): cardiovascular; hepatic toxicity; medicinal plant; miscarriage; ovarian cancer; PCOS
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test